POMDOCTOR LIMITED Valuation
| POM Stock | 0.24 0.01 4.35% |
POMDOCTOR LIMITED seems to be fairly valued based on Macroaxis valuation methodology. Our model determines the value of POMDOCTOR LIMITED from inspecting the company fundamentals such as revenue of 342.56 M, and Number Of Shares Shorted of 226.09 K as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting POMDOCTOR LIMITED's valuation include:
Price Sales 1.5248 |
Fairly Valued
Today
Please note that POMDOCTOR LIMITED's price fluctuation is out of control at this time. Calculation of the real value of POMDOCTOR LIMITED is based on 3 months time horizon. Increasing POMDOCTOR LIMITED's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the POMDOCTOR stock is determined by what a typical buyer is willing to pay for full or partial control of POMDOCTOR LIMITED American. Since POMDOCTOR LIMITED is currently traded on the exchange, buyers and sellers on that exchange determine the market value of POMDOCTOR Stock. However, POMDOCTOR LIMITED's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.24 | Real 0.23 | Hype 0.24 |
The intrinsic value of POMDOCTOR LIMITED's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence POMDOCTOR LIMITED's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of POMDOCTOR LIMITED American helps investors to forecast how POMDOCTOR stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of POMDOCTOR LIMITED more accurately as focusing exclusively on POMDOCTOR LIMITED's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use POMDOCTOR LIMITED's intrinsic value based on its ongoing forecasts of POMDOCTOR LIMITED's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against POMDOCTOR LIMITED's closest peers.
POMDOCTOR LIMITED Cash |
|
About POMDOCTOR LIMITED Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of POMDOCTOR LIMITED American. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of POMDOCTOR LIMITED based exclusively on its fundamental and basic technical indicators. By analyzing POMDOCTOR LIMITED's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of POMDOCTOR LIMITED's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of POMDOCTOR LIMITED. We calculate exposure to POMDOCTOR LIMITED's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of POMDOCTOR LIMITED's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 42.9 M | 40.8 M | |
| Pretax Profit Margin | (0.10) | (0.10) | |
| Operating Profit Margin | (0.07) | (0.07) | |
| Net Loss | (0.38) | (0.40) | |
| Gross Profit Margin | 0.16 | 0.20 |
POMDOCTOR LIMITED Current Valuation Indicators
POMDOCTOR LIMITED's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final POMDOCTOR LIMITED's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as POMDOCTOR LIMITED, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use POMDOCTOR LIMITED's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes POMDOCTOR LIMITED's worth.When determining whether POMDOCTOR LIMITED is a strong investment it is important to analyze POMDOCTOR LIMITED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact POMDOCTOR LIMITED's future performance. For an informed investment choice regarding POMDOCTOR Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in POMDOCTOR LIMITED American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Pharmaceutical Retailers sector continue expanding? Could POMDOCTOR diversify its offerings? Factors like these will boost the valuation of POMDOCTOR LIMITED. Anticipated expansion of POMDOCTOR directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every POMDOCTOR LIMITED data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate POMDOCTOR LIMITED using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating POMDOCTOR LIMITED's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause POMDOCTOR LIMITED's market price to deviate significantly from intrinsic value.
It's important to distinguish between POMDOCTOR LIMITED's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding POMDOCTOR LIMITED should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, POMDOCTOR LIMITED's market price signifies the transaction level at which participants voluntarily complete trades.